NEJM reports that DTC spend increased 330% between '96-'05

Share this article:
In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising increased by 330% between 1996 and 2005, while the number of warning and untitled letters issued on ads fell from 142 in 1997 to 21 in 2006.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.